Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03069105 · ClinicalTrials.gov registry record
An Exploratory Study of Caregiver Burden Among Family Caregivers of Patients With Cancer
A clinical trial, sponsored by Saint John's Cancer Institute.
- Completed
- Registry status
- 49
- Enrollment target
NCT03069105: Completed study, sponsored by Saint John's Cancer Institute.
NCT03069105 is a clinical trial that has completed, run by Saint John's Cancer Institute. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03069105 has completed, sponsored by Saint John's Cancer Institute.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
This study will look at caregiver burden and the coping behavior of caregivers of patients with cancer. Through this study, the investigators will identify the relationship between cognitive dysfunction (measured as a proxy rating by the caregiver), resilience, social support, cognitive appraisal, coping behavior, and caregiver burden, anxiety, and depression among family caregivers of patients with cancer.
Primary Outcome
Relation between caregiver burden subscale scores and caregiver resilience, social support, and coping
Interventions
- OTHER Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2017-02-23 |
| Est. Completion | 2020-04-28 |
What the finished NCT03069105 record still lists
NCT03069105 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 49 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.
NCT03069105 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03069105 about?
NCT03069105 is a clinical study titled "An Exploratory Study of Caregiver Burden Among Family Caregivers of Patients With Cancer". This study will look at caregiver burden and the coping behavior of caregivers of patients with cancer. Through this study, the investigators will identify the relationship between cognitive dysfunction (measured as a proxy rating by the caregiver), resilience, social support, cognitive appraisal, c...
What is the current status of trial NCT03069105?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2017-02-23. Estimated completion is 2020-04-28.
What interventions are being tested in trial NCT03069105?
The interventions under investigation include: Questionnaire (OTHER).
Who is sponsoring clinical trial NCT03069105?
This trial is sponsored by Saint John's Cancer Institute, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI